Latest News and Press Releases
Want to stay updated on the latest news?
-
HUTCHINSON, Minn., April 15, 2008 (PRIME NEWSWIRE) -- Hutchinson Technology Incorporated (Nasdaq:HTCH) today announced it will report fiscal second quarter 2008 financial results on Tuesday, April 29,...
-
Andersen & Martini A/S har i dag modtaget meddelelse fra Multi-Invest Danmark A/S om, at dette selskab har erhvervet 241.200 aktier i Andersen & Martini A/S. Meddelelsen vedhæftes nærværende...
-
HOUSTON, April 15, 2008 (PRIME NEWSWIRE) -- Crown Castle International Corp. (NYSE:CCI) today announced plans to release its first quarter 2008 results on Wednesday, April 23, 2008 after the market...
-
YOQNEAM, ISRAEL--(Marketwire - April 15, 2008) - MIND C.T.I. LTD. (NASDAQ: MNDO), a leading provider of convergent end-to-end billing and customer care product based solutions for tier 2 and tier 3...
-
CLEVELAND, April 15, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its first quarter 2008 financial results at approximately 4:00 PM (Eastern Time) on Thursday,...
-
EAST LANSING, Mich., April 15, 2008 (PRIME NEWSWIRE) -- American Physicians Capital, Inc. (APCapital) (Nasdaq:ACAP) expects to release its first quarter 2008 earnings on Thursday, May 1, 2008, after...
-
SAN JUAN CAPISTRANO, Calif., April 15, 2008 (PRIME NEWSWIRE) -- American Mold Guard, Inc. (Nasdaq:AMGI) announced today that on April 9, 2008 it received a determination letter from the staff of The...
-
ATLANTA, April 15, 2008 (PRIME NEWSWIRE) -- MedAvant Healthcare Solutions (MedAvant) (Nasdaq:PILL), a leader in healthcare technology and transaction services, today announced results for the fourth...
-
THE WOODLANDS, Texas, April 15, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), a leader in genomics-based drug discovery, presented data today describing the target of LX6171...
-
Summary: Genmab has announced that HuMax-EGFr (zalutumumab) inhibits epidermal growth factor receptor signaling by locking epidermal growth factor receptor (EGFr) molecules into a very...